Citigroup Inc Medicinova Inc Transaction History
Citigroup Inc
- $217 Billion
- Q3 2025
A detailed history of Citigroup Inc transactions in Medicinova Inc stock. As of the latest transaction made, Citigroup Inc holds 594,057 shares of MNOV stock, worth $908,907. This represents 0.0% of its overall portfolio holdings.
Number of Shares
594,057
Previous 591,957
0.35%
Holding current value
$908,907
Previous $775,000
3.48%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MNOV
# of Institutions
25Shares Held
5.03MCall Options Held
0Put Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.69 Million0.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA700KShares$1.07 Million0.0% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.06 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA530KShares$810,4440.0% of portfolio
-
Ubs Group Ag222KShares$340,0680.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $75M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...